283 related articles for article (PubMed ID: 3930551)
1. Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal men.
Evans WS; Vance ML; Kaiser DL; Sellers RP; Borges JL; Downs TR; Frohman LA; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1985 Nov; 61(5):846-50. PubMed ID: 3930551
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM
J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
[TBL] [Abstract][Full Text] [Related]
4. Dose-effect study of intranasal administration of growth hormone-releasing hormone-44-NH2 in healthy subjects.
Khalfallah Y; Navailles B; Cohen R; Laville P; Kalita C; Cabrera P; Frangin G; Sassolas G
J Clin Endocrinol Metab; 1990 Aug; 71(2):512-5. PubMed ID: 2116440
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone-releasing hormone infusion in patients with active acromegaly.
Losa M; Chiodini PG; Liuzzi A; König A; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
Barbarino A; Corsello SM; Della Casa S; Tofani A; Sciuto R; Rota CA; Bollanti L; Barini A
J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
[TBL] [Abstract][Full Text] [Related]
7. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
Alba-Roth J; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man.
Vance ML; Kaiser DL; Evans WS; Thorner MO; Furlanetto R; Rivier J; Vale W; Perisutti G; Frohman LA
J Clin Endocrinol Metab; 1985 Feb; 60(2):370-5. PubMed ID: 3917460
[TBL] [Abstract][Full Text] [Related]
9. Intranasal administration of neostigmine potentiates both intravenous and intranasal growth hormone (GH)-releasing hormone-induced GH release in short children.
Ghigo E; Procopio M; Bellone J; Mazza E; Mucci M; Boghen MF; Müller EE; Camanni F
J Clin Endocrinol Metab; 1991 Feb; 72(2):467-70. PubMed ID: 1991816
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
[TBL] [Abstract][Full Text] [Related]
11. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men.
Hartman ML; Farello G; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1992 Jun; 74(6):1378-84. PubMed ID: 1592884
[TBL] [Abstract][Full Text] [Related]
13. Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor-I levels in old men.
Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
J Clin Endocrinol Metab; 1993 Jan; 76(1):134-8. PubMed ID: 8421077
[TBL] [Abstract][Full Text] [Related]
14. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.
Ghigo E; Arvat E; Gianotti L; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F
J Clin Endocrinol Metab; 1994 Mar; 78(3):693-8. PubMed ID: 8126144
[TBL] [Abstract][Full Text] [Related]
16. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
Rosenthal SM; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
[TBL] [Abstract][Full Text] [Related]
17. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.
Hulse JA; Rosenthal SM; Cuttler L; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1986 Oct; 63(4):872-8. PubMed ID: 3091629
[TBL] [Abstract][Full Text] [Related]
18. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency.
Hanew K; Goh M; Sato S; Shimizu Y; Sasaki A; Aida M; Yoshinaga K
J Clin Endocrinol Metab; 1988 Apr; 66(4):715-21. PubMed ID: 3126213
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of hypothalamic dysfunction in growth hormone (GH)-deficient patients using single versus multiple doses of GH-releasing hormone (GHRH-44) and evidence for diurnal variation in somatotroph responsiveness to GHRH in GH-deficient patients.
Schriock EA; Hulse JA; Harris DA; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1177-82. PubMed ID: 3119651
[TBL] [Abstract][Full Text] [Related]
20. Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH.
Vance ML; Kaiser DL; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1986 Mar; 62(3):591-4. PubMed ID: 3080467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
